Laso Healthcare Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.50 M
- Company Age 11 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.50 M
- Satisfied Charges ₹ 1.50 M
- Revenue Growth 4.32%
- Profit Growth -102.30%
- Ebitda -74.90%
- Net Worth -0.67%
- Total Assets 1.32%
About Laso Healthcare
Laso Healthcare Private Limited (LHPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 May 2013 and has a history of 11 years and nine months. Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹2.50 M. The company has closed loans amounting to ₹1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Latha and Akila Thiyagarajan serve as directors at the Company.
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33110TN2013PTC091023
- Company No.
091023
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 May 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Laso Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Latha  | Director | 08-May-2013 | Current |
| Akila Thiyagarajan | Director | 28-Jun-2018 | Current |
Financial Performance of Laso Healthcare.
Laso Healthcare Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.32% increase. The company also saw a substantial fall in profitability, with a 102.3% decrease in profit. The company's net worth dipped by a decrease of 0.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Laso Healthcare?
In 2023, Laso Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.50 M
₹1.50 M
Charges Breakdown by Lending Institutions
- Karnataka Bank Ltd. : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Mar 2019 | Karnataka Bank Ltd. | ₹2.50 M | Open |
| 21 Aug 2017 | Karnataka Bank Ltd. | ₹1.50 M | Satisfied |
How Many Employees Work at Laso Healthcare?
Unlock and access historical data on people associated with Laso Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Laso Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Laso Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
